Selank is a nootropic, anxiolytic peptide based drug developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. Selank is a heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is a synthetic analogue of a human tetrapeptide tuftsin.
1. Selank improvement of learning and memory processes;
2. Selank increased sensory attention;
3. Selank increased curiosity;
4. Selank increased mental clarity;
5. Selank restoration of balance of serotonergic and noradrenergic brain system activity;
6. Selank anti-anxiety - inhibition of anxiety;
7. Selank antiviral activity with no negative effects;
8. Selank psychostimulant, anti-asthenic - increased mental energy stabilization of mood and overall feeling of wellbeing reversal of anhedonia potential restoration of catecholaminergic system functions after damage due to abuse reference.
